Directory
Jose Manuel Valdivielso Revilla

Jose Manuel Valdivielso Revilla

Degree: PhD

973 702 952
valdivielso(ELIMINAR)@irblleida.cat

ResearcherID: http://www.researcherid.com/rid/B-5673-2009

Publications

  • Bozic, M; Caus, M; Rodrigues-Diez, RR; Pedraza, N; Ruiz-Ortega, M; Gari, E; Gallel, P; Panades, MJ; Martinez, A; Fernandez, E; Valdivielso, JM

    Protective role of renal proximal tubular alpha-synuclein in the pathogenesis of kidney fibrosis.

    Nature Communications 11 1943-1943. .

    [doi:10.1038/s41467-020-15732-9]

  • Martinez-Sena, T; Soluyanova, P; Guzman, C; Valdivielso, JM; Castell, JV; Jover, R

    The Vitamin D Receptor Regulates Glycerolipid and Phospholipid Metabolism in Human Hepatocytes.

    Biomolecules 10 -. .

    [doi:10.3390/biom10030493]

  • Solache-Berrocal, G; Barral-Varela, AM; Areces-Rodriguez, S; Junco-Vicente, A; Vallina-Alvarez, A; Corte-Torres, MD; Valdivielso, JM; Llosa, JC; Moris, C; Martin, M; Rodriguez, I

    Correlation of Micro-Computed Tomography Assessment of Valvular Mineralisation with Histopathological and Immunohistochemical Features of Calcific Aortic Valve Disease

    Journal of Clinical Medicine 9 -. .

    [doi:10.3390/jcm9010029]

  • Palau, V; Riera, M; Duran, X; Valdivielso, JM; Betriu, A; Fernandez, E; Pascual, J; Soler, MJ

    Circulating ADAMs are associated with renal and cardiovascular outcomes in chronic kidney disease patients.

    NEPHROLOGY DIALYSIS TRANSPLANTATION 35 130-138. .

    [doi:10.1093/ndt/gfy240]

  • Valdivielso JM; Bozic M; Galimudi RK; Bermudez-López M; Navarro-González JF; Fernández E; Betriu À

    Association of the rs495392 Klotho polymorphism with atheromatosis progression in patients with chronic kidney disease

    NEPHROLOGY DIALYSIS TRANSPLANTATION 34 2079-2088. .

    [doi:10.1093/ndt/gfy207]

  • Sanchez, E; Lecube, A; Betriu À; Hernandez, C; Lopez-Cano, C; Gutierrez-Carrasquilla, L; Kerkeni, M; Yeramian, A; Purroy, F; Pamplona, R; Farràs C; Fernandez, E; Barbe, F; Simo, R; ILERVAS project; Hernández M; Rius F; Polanco D; de la Torre MS; Torres G; Godoy P; Portero-Otin M; Jové M; Colàs-Compàs L; Benabdelhak I; Miquel E; Ortega M; Valdivielso JM; Bermúdez M; Martínez-Alonso M

    Subcutaneous advanced glycation end-products and lung function according to glucose abnormalities: The MR-1 ILERVAS Project

    Diabetes & metabolism 45 595-598. .

    [doi:10.1016/j.diabet.2018.04.002]

  • Valdivielso, JM; Rodriguez-Puyol, D; Pascual, J; Barrios, C; Bermudez-Lopez, M; Sanchez-Nino, MD; Perez-Fernandez, M; Ortiz, A

    Atherosclerosis in Chronic Kidney Disease More, Less, or Just Different?

    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY 39 1938-1966. .

    [doi:10.1161/ATVBAHA.119.312705]

  • Martinez-Lopez, D; Roldan-Montero, R; Garcia-Marques, F; Nunez, E; Jorge, I; Camafeita, E; De Cordoba, SR; Valdivieso, JM; Michel, JB; Blanco-Colio, LM; Vazquez, J; Martin-Ventura, JL

    TOPOLOGICALLY-RESOLVED PROTEOMICS OF EARLY HUMAN ATHEROSCLEROTIC PLAQUES REVEALS COMPLEMENT C5 AS A BIOMARKER OF SUBCLINICAL ATHEROSCLEROSIS

    MOLECULAR IMMUNOLOGY 114 474-474. .

  • Forné, Carles; Cambray, Serafi; Bermudez-Lopez, Marcelino; Fernandez, Elvira; Bozic, Milica; Valdivielso, Jose M

    Machine learning analysis of serum biomarkers for cardiovascular risk assessment in chronic kidney disease

    CLINICAL KIDNEY JOURNAL 13 631-639. .

    [doi:10.1093/ckj/sfz094]

  • Palanca, A; Castelblanco, E; Betriu À; Perpiñán H; Soldevila, B; Valdivielso, JM; Bermudez-Lopez, M; Puig-Jove, C; Puig-Domingo, M; Groop, PH; Fernandez, E; Alonso, N; Mauricio, D

    Subclinical atherosclerosis burden predicts cardiovascular events in individuals with diabetes and chronic kidney disease

    Cardiovascular Diabetology 18 93-93. .

    [doi:10.1186/s12933-019-0897-y]

  • Bermudez-Lopez M; Forne C; Amigo N; Bozic M; Arroyo D; Bretones T; Alonso N; Cambray S; Del Pino MD; Mauricio D; Gorriz JL; Fernandez E; Valdivielso JM

    An in-depth analysis shows a hidden atherogenic lipoprotein profile in non-diabetic chronic kidney disease patients

    Expert Opinion On Therapeutic Targets 23 619-630. .

    [doi:10.1080/14728222.2019.1620206]

  • Bozic, M; Caus, M; Rodrigues-Diez, RR; Ruiz-Ortega, M; Martinez, A; Blasco, A; Gallel, P; Fernandez, E; Valdivielso, JM

    ALPHA-SYNUCLEIN MAINTAINS THE EPITHELIAL PHENOTYPE AND PROTECTS FROM RENAL FIBROSIS

    NEPHROLOGY DIALYSIS TRANSPLANTATION 34 156-156. .

Projects

  • Estancias de personal docente y/o investigador senior en centros extranjeros 2022
  • El primer Estudio de asociación de genoma completo (GWAS) con enfermedad coronaria poblacional a 10 años en más de 100.000 participantes para personalizar la prevención cardiovascular en España
  • Influence of SARS-COV-2 infection in atherosclerosis development. “El BUS DE LA SALUT” study
  • SPAIN CKD CAUSE (SPACKDC)
  • INVESTIGO 2022: Grup de recerca translacional vascular i renal
  • Papel de PTEN en la reabsorcion tubular renal de proteinas. Implicaciones en nefropatias proteinuricas
  • Preservació la membrana peritoneal abordant noves vies per inhibir la transició mesotelio-mesenquimal.
  • Acciones de Dinamización "Europa Investigación 2020"
  • Contratos Sara Borrell
  • Papel de la vía PI3K/AKT/mTOR en la regulación de las alteraciones del metabolismo mineral en la enfermedad renal crónica. Implicaciones en la regulación de la síntesis de FGF23.
  • Ajuts destinats a contractar personal investigador novell (FI)
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA CIENTIFICA BASICA PER A LA CARACTERITZACIO D'UN PERFIL LIPIDOMICO Y LIPIDICO DE RIESGO ATEROGENERICO Y DE MORBIMORTALIDAD CARDIOVASCUAL EN LA ENFERMEDAD RENAL CRONICA (ESTADIOS 3 A 5), ESTUDIO PROSPECTIVO NEFRONA.